CBX Therapeutics
General Data
Reg Number
516839875
Sector
Biomed
Established
2024
No. of Employees
4
Stage
R&D
Additional Funding
1
Description
CBX developed CLARIFY, a proprietary platform identifying synergistic cannabinoid combinations for neurological diseases. Its first lead, CBX-38 for Parkinson’s, is ready for clinical translation, backed by preclinical PoC and early human data.
Technology
Medical cannabis, cannabinoids.
Targeted Customers
Patients who suffer from Parkinson's disease and other neurological disorders.
Management personnel
Shimon Lecht - CEO & Founder
Winning details
Route name
Winning year
Periphery Entrepreneurship Incubators
Periphery Entrepreneurship Incubators
2023